Page 21 - Data Management Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com's offering. Asia-Pacific's pharmaceutical CRO market will grow by 9.6% annually with a total addressable market cap of $238.7 billion over 2020-2030 owing to the rising incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 33 tables and 44 figures, this report is based on comprehensive research of the entire Asia-Pacific pharmaceutical CRO market and all its sub-segments through extensively detailed classifications...

Pharmaceutical Contract Research Organization (CRO) Market Global pharmaceutical CRO market will reach $104.4 billion by 2030, growing by 8.1% annually over 2020-2030 driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 85 tables and 77 figures, this 168-page report “Global Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity” is base...

Share this article Share this article ResearchAndMarkets.com's offering. The European pharmaceutical CRO market accounted for $11.96 billion in 2019 and will grow by 7.9% annually over 2020-2030 owing to the rising incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 36 tables and 45 figures, this report is based on comprehensive research of the entire Europe pharmaceutical CRO market and all its sub-segments through extensively detailed classifications. Profound analysis a...

Share this article Share this article ResearchAndMarkets.com's offering. The Global pharmaceutical CRO market will reach $104.4 billion by 2030, growing by 8.1% annually over 2020-2030 driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and...

Porter's Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical CDMO market in every aspect of the classification from perspectives of Category, Service Type, Therapeutic Application, End User, and Country. Based on Category, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Pharmaceutical Industry Biopharmaceutical Industry Based ...